- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03668938
Occupational Therapy Intervention in Patients With Complex Needs to Improve Social Reintegration
July 28, 2022 updated by: Stefania Fugazzaro, Arcispedale Santa Maria Nuova-IRCCS
Efficacy of Occupational Therapy in the Rehabilitation of Complex Patients: Randomized Controlled Trial
A previous study that involved the intervention of the occupational therapist (OT) on complex patients both in hospital and at home showed the effectiveness of OT during hospitalization.
The effectiveness was not demonstrated in the post-discharge phase.
Now, the investigators presented a RCT to compare the levels of social reintegration between the intervention group and control group.
The hypothesis is that the intervention group obtains a higher and clinically relevant level of social reintegration compared to the group treated with the usual care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In the previous study, the intervention group achieved higher gains in the return to normal life than in the control group, but this difference did not reach statistical significance.
Because of this, a new study was implemented with the correct sample size, defined through the previous study.
In addition, the post-discharge phase the COPM was administered to define new objectives relating mainly to productivity and leisure time areas.
Finally, the investigators have indentified some territorial services with the aim to create tailored paths/interventions for patients to promote social reintegration.
Study Type
Interventional
Enrollment (Actual)
92
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Reggio Emilia, Italy
- Ospedale Santa Maria Nuova
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Complex impatient
- Admitted to AUSL-IRCCS/UO MFR
Exclusion Criteria:
- Language barriers
- Severe cognitive impairment
- Psychiatric disorders
- Domiciled in a protected facility at the time of admission
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: usual care
Usual care consists in rehabilitation treatment delivered by a multidisciplinary team
|
Usual care consists in rehabilitation treatment delivered by a multidisciplinary team
|
Experimental: intervention
The occupational therapy intervention provides a treatment aimed at improving autonomy in the activities chosen by the patient
|
The intervention in the hospitalization phase is mainly aimed at achieving the objectives related to the self-care area and, secondly, to the objectives in the areas of productivity and leisure time, identified in T0 and to the environmental assessment of the places of life of the patient; more an intervention in the patient's post-discharge home, mainly aimed at achieving the objectives related to social reintegration, the area of productivity and leisure time and, secondly, to possible objectives in the areas of self-care identified in T1.
Usual care consists in rehabilitation treatment delivered by a multidisciplinary team
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Reintegration to Normal Living Index
Time Frame: Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Compare the change in the level of reintegration to normal life between the two arms.
The score range is from 1 to 100.
Higher values represent a better outcome.
|
Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Canadian Occupational Performance Measure
Time Frame: Time 0 is the baseline at the patient ammission in the rehabilitation ward; Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Compare the results obtained in the two groups in the performance and satisfaction perceived by the patient in carrying out the occupational activities identified as priorities.
The score range is from 1 to 10. Higher values represent a better outcome.
|
Time 0 is the baseline at the patient ammission in the rehabilitation ward; Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Modified Barthel Index
Time Frame: Time 0 is the baseline at the patient ammission in the rehabilitation ward; Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Compare the results obtained in the two groups in autonomy in the activities of daily life.
The score range is from 1 to 100.
Higher values represent a better outcome.
|
Time 0 is the baseline at the patient ammission in the rehabilitation ward; Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Instrumental Activity of Daily Living
Time Frame: Time 0 is the baseline at the patient ammission in the rehabilitation ward; Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Compare the results obtained in the two groups in autonomy in instrumental activities.
The score range is from 1 to 8. Lower values represent a better outcome.
|
Time 0 is the baseline at the patient ammission in the rehabilitation ward; Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Hospital Anxiety and Depression Scale
Time Frame: Time 0 is the baseline at the patient ammission in the rehabilitation ward; Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Compare the results obtained in the two groups in anxiety and depression.The scale has 2 subscales that evaluates anxiety and depression, respectively.
For both subscales the score range is from 0 to 21.
Higher values represent a better outcome.
|
Time 0 is the baseline at the patient ammission in the rehabilitation ward; Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Short Form 12
Time Frame: Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Compare the results obtained in the two groups in the quality of life.
The scale has 2 subscales.
The Physical Component Summary has a score range from 11 to 70.
The other subscale evaluates the Mental Component Summary with a score range from 7 to 72.
Higher values represent a better outcome.
|
Time 1 is on average 45 days from Time 0 (discharge from the rehabilitation ward); Time 2 is at 90 days ± 15 days from discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Stefania Fugazzaro, Local Health Autority of Reggio Emilia
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 8, 2018
Primary Completion (Actual)
September 23, 2020
Study Completion (Actual)
September 23, 2020
Study Registration Dates
First Submitted
August 14, 2018
First Submitted That Met QC Criteria
September 11, 2018
First Posted (Actual)
September 13, 2018
Study Record Updates
Last Update Posted (Actual)
July 29, 2022
Last Update Submitted That Met QC Criteria
July 28, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Other Study ID Numbers
- COMPLE-TO_2018
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rehabilitation
-
Westfälische Wilhelms-Universität MünsterNational Paralympic Committee Germany (NPCG)CompletedCardiac Rehabilitation | Feasibility Studies | Organization and Administration | Rehabilitation ExerciseGermany
-
Asan Medical CenterRecruitingPulmonary Rehabilitation | Cardiac RehabilitationKorea, Republic of
-
University Hospital, ToursCompletedPulmonary Rehabilitation | Respiratory RehabilitationFrance
-
Suleyman Demirel UniversityCompleted
-
Orton Orthopaedic HospitalCompleted
-
Cairo UniversityRecruiting
-
Bruyere Research InstituteBruyere Academic Medical OrganizationRecruiting
-
National Cheng Kung UniversityRecruiting
-
University College AbsalonUniversity of Southern Denmark; Arla Foods; Danish Council for Independent Research and other collaboratorsCompleted
-
Groupe Hospitalier Paris Saint JosephWithdrawn
Clinical Trials on Occupational Therapy
-
University of WashingtonTerminatedBreast Cancer | Breast Cancer Stage I | Breast Cancer Stage II | Breast Cancer Stage III | Breast Cancer Stage IIB | Breast Cancer Stage IIA | Breast Cancer Stage IIIA | Breast Cancer Stage IIIB | Breast Cancer Stage IIIcUnited States
-
NYU Langone HealthCompletedde Quervain's DiseaseUnited States
-
University of Alabama at BirminghamCompleted
-
University of MalagaCompletedWell-being | Individuality | Self-EfficacySpain
-
Hacettepe UniversityAuthorsCompleted
-
Children's Hospital Medical Center, CincinnatiCompletedAutism Spectrum Disorder | Attention Deficit Hyperactivity DisorderUnited States
-
First Affiliated Hospital Xi'an Jiaotong UniversityXijing Hospital; Children's Hospital of Fudan University; Shaanxi Provincial... and other collaboratorsUnknownCerebral Palsy | Brain Injury, ChronicChina
-
Cliniques universitaires Saint-Luc- Université...RecruitingSevere Chronic Obstructive Pulmonary DiseaseBelgium
-
Taipei City HospitalCompletedOccupational Therapy | Psychiatric RehabilitationTaiwan
-
Taipei Medical University HospitalRecruiting